Due to the proliferation of antibiotics and the careless disposal of these drugs into the environment, many drug-resistant strains of bacteria have started popping up. Aptly called Superbugs, these microorganisms have become such a major threat that scientists are now considering crazy solutions. Among them is to use viruses to kill the bacteria with the help of artificial intelligence.
As Futurism notes, the use of viruses to treat patients infected with Superbugs is often considered a last resort. Called bacteriophage or phage, previous methods have proven to be inaccurate, which made them less reliable than conventional medicine.
Unfortunately, the current state of bacterial infection has become desperate. That’s why companies like Adaptive Phage Therapeutics are coming up with better ways to analyze the genetic data of bacteria to match them with the right phage. This is where AI comes in since the data processing capabilities of machines can significantly shorten the amount of time needed to accomplish these tasks.
Speaking to MIT Review, Adaptive Phage Therapeutics CEO Greg Merril said that time is of the essence when Superbugs infect patients. Many of them don’t have the hours or days it takes to actually sequence the genetic code of bacteria and then match them with the right treatment.
“When a patient is critically ill, every minute is important,” Merril said.
At this point, these methods are still in their infancy and are nowhere near ready to be used on humans. Clinical trials are already underway, but the rate of the spread and growth of Superbugs might spur the government to focus on this issue sooner or later. Once even the most potent antibiotics are no longer able to treat what used to be minor infections, there are going to be a lot of deaths.
The drug companies haven’t exactly advanced that far in researching new drugs to fight bacteria over the last few decades.


Apple Earnings Beat Expectations as iPhone Sales Surge to Four-Year High
NASA Partners with Katalyst to Save Swift Observatory with Innovative Docking Mission
Meta Faces Lawsuit Over Alleged Approval of AI Chatbots Allowing Sexual Interactions With Minors
SpaceX Updates Starlink Privacy Policy to Allow AI Training as xAI Merger Talks and IPO Loom
ASML’s EUV Lithography Machines Power Europe’s Most Valuable Tech Company
Microsoft AI Spending Surge Sparks Investor Jitters Despite Solid Azure Growth
NASA Astronauts Wilmore and Williams Recover After Boeing Starliner Delay
China Approves First Import Batch of Nvidia H200 AI Chips Amid Strategic Shift
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options
Meta Stock Surges After Q4 2025 Earnings Beat and Strong Q1 2026 Revenue Outlook Despite Higher Capex
Neuren Pharmaceuticals Surges on U.S. Patent Win for Rare Disorder Drug
Nvidia’s $100 Billion OpenAI Investment Faces Internal Doubts, Report Says
Neuralink Expands Brain Implant Trials with 12 Global Patients
Apple Forecasts Strong Revenue Growth as iPhone Demand Surges in China and India 



